Abstract:Rationale: The cellular mechanisms of obesity/hyperlipidemia-induced cardiac remodeling are many and not completely elucidated. Ca2+/calmodulin-dependent protein kinase II (CaMKII), a multifunctional serine/threonine kinase, has been reported to be involved in a variety of cardiovascular diseases. However, its role in obesity/hyperlipidemia-induced cardiac remodeling is still unknown.Objective: The objective of this study was to demonstrate the role of CaMKII in the pathogenesis of obesity/hyperlipidemia-induced cardiac remodeling both in vitro and in vivo.Methods and results: In cardiac -derived H9C2 cells, palmitate treatment induced cell apoptosis coupled with activation of the mitochondrial apoptotic pathway, and cell hypertrophic and fibrotic responses. All of these alterations were inhibited by pharmacological inhibition of CaMKII with either of two specific inhibitors, Myr-AIP and KN93. In addition, an increased inflammatory response coupled with activation of the MAPKs and NF-kappa B signaling pathway, exaggerated oxidative stress, ER stress and autophagy were also observed in palmitate-treated H9C2 cells, while pretreatment with CaMKII inhibitors decreased these pathological signals. Furthermore, we also demonstrated that TLR4 is upstream signal of CaMKII in palmitate-treated H9C2 cells. In APOE(-/-) mice fed a high -fat diet (HFD) for 16 weeks, serum lipid profiles (FFAs, TG, TC) and blood glucose levels were significantly increased compared with mice fed a normal diet. In addition, apparent cardiac hypertrophy, fibrosis and apoptosis associated with increased inflammation, ER stress, and autophagy were also observed in the hearts of HFD-fed mice. However, all these changes were reversed by 8 -weeks of KN93 peritoneal injections. KN93 also increased antioxidant defense as evidenced by increased expression of the Nrf2 system in the hearts of HFD-fed mice.Conclusions: Taken together, our results demonstrate a critical role of CaMKII in the pathogenesis of obesity/hyperlipidemia-induced cardiac remodeling. Also, TLR4 may be an upstream signal of cardiac CaMKII under hyperlipidemia conditions. These results suggest that CaMKII has the potential to be a therapeutic target in the prevention of obesity/hyperlipidemia-induced cardiac remodeling. (C) 2017 Published by Elsevier Ltd.

Corrigendum to “role of CaMKII in Free Fatty Acid/hyperlipidemia-Induced Cardiac Remodeling Both in Vitro and in Vivo” [J. Mol. Cell. Cardiol. 109 (2017) 1–16]

Role of CaMKII in Free Fatty Acid/hyperlipidemia-Induced Cardiac Remodeling Both in Vitro and in Vivo.

Relaxin Inhibits Cardiac Fibrosis and Endothelial–mesenchymal Transition Via the Notch Pathway [Corrigendum]

Erratum: Metoprolol and bisoprolol ameliorate hypertrophy of neonatal rat cardiomyocytes induced by high glucose via the PKC/NF-κB/c-fos signaling pathway.

003CaMKII as a pathological mediator of inflammation, oxidative stress, ER stress, autophagy and mitochondrial dysfunction in free fatty acids/hyperlipidemia-induced cardiac remodeling both in vitro and vivo

Corrigendum: Adiponectin Modified BMSCs Alleviate Heart Fibrosis Via Inhibition TGF-beta1/smad in Diabetic Rats

Theoretical Investigation Of The Mechanism Of Heart Failure Using A Canine Ventricular Cell Model: Especially The Role Of Up-Regulated Camkii And Sr Ca2+ Leak

Corrigendum to “knockdown of Herp Alleviates Hyperhomocysteinemia Mediated Atherosclerosis Through the Inhibition of Vascular Smooth Muscle Cell Phenotype Switching” [int. J. Cardiol. 269 (2018) 242–249]

CaMKII: do not work too hard in the failing heart.

Corrigendum to Increased Expression of DRAM1 Confers Myocardial Protection Against Ischemia Via Restoring Autophagy Flux [J Mol Cell Cardiol. 2018 Nov;124:70–82]

Corrigendum: a novel αB-crystallin R123W variant drives hypertrophic cardiomyopathy by promoting maladaptive calcium-dependent signal transduction

Corrigendum to “FUNDC1 Insufficiency Sensitizes High Fat Diet Intake-Induced Cardiac Remodeling and Contractile Anomaly Through ACSL4-mediated Ferroptosis” [metabolism 122 (september 2021) 154840]

Corrigendum to "Zhang Y, Han X, Hu N, Huff AF, Gao F, Ren J. Akt2 knockout alleviates prolonged caloric restriction-induced change in cardiac contractile function through regulation of autophagy. [J Mol Cell Cardiol. 2014 Jun; 71:81-91. PMID: 24368095].

PI3K-Akt signaling,but not CaMKIIγ,compensates for loss of CaMKIIδin mediating hypertrophic responses

Corrigendum to “TRPA1 Inhibition Ameliorates Pressure Overload-Induced Cardiac Hypertrophy and Fibrosis in Mice” [ebiomedicine (2018) 54–62]

Erratum to "akt2 Knockout Alleviates Prolonged Caloric Restriction-Induced Change in Cardiac Contractile Function Through Regulation of Autophagy" [J. Mol. Cell. Cardiol. 71 (2014 Jun) 81-91. PMID: 24368095].

CaMKII Inhibition in Heart Failure, Beneficial, Harmful, or Both.

Corrigendum: The Emerging Role of Rho Guanine Nucleotide Exchange Factors in Cardiovascular Disorders: Insights Into Atherosclerosis: A Mini Review

[Corrigendum] Exosomal microRNA‑4516, microRNA‑203 and SFRP1 are potential biomarkers of acute myocardial infarction

Corrigendum to “inhibition of PARP Prevents Angiotensin II-induced Aortic Fibrosis in Rats”. [int. J. Cardiol. (2013 Sep 1) 167(5) 2285–2293]

Corrigendum: Characterising an Alternative Murine Model of Diabetic Cardiomyopathy